SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1899 participants.
Also called NCT05198674
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,899 participants
- Sponsor
- Registry
-
NCT05198674
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States, Australia, Belgium, France, Germany, Greece, Ireland, Monaco, Netherlands, Sweden, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05198674. Allocation not applicable; no masking; primary purpose treatment. Start 2021-10-20 (actual); primary completion 2026-03-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
- Condition
- Hypertension
- Condition
- Vascular Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Chronic Kidney Diseases
- Condition
- Diabetes Mellitus
- Intervention (Device)
- Renal Denervation (Symplicity Spyral™)
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct05198674- Content hash
e4da58c25b06d17ca20c9077810124d782678a9788c7be94189747138c910cc8